omega-n-methylarginine has been researched along with nifedipine in 14 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (nifedipine) | Trials (nifedipine) | Recent Studies (post-2010) (nifedipine) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 16,024 | 2,496 | 1,505 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (57.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizusawa, H; Omote, M | 1 |
| Cocks, TM; Kilpatrick, EV | 1 |
| Gross, SS; Mitchell, JA; Szabó, C; Thiemermann, C; Vane, JR | 1 |
| Chaturvedi, UC; Misra, A; Mukerjee, R | 1 |
| Boer, P; Dijkhorst-Oei, LT; Koomans, HA; Rabelink, TJ | 1 |
| Choate, JK; Paterson, DJ; Sears, CE | 1 |
| Beutler, JJ; Dijkhorst-Oei, LT; Koomans, HA; Rabelink, TJ; Stroes, ES | 1 |
| Milstone, DS; Mortensen, RM; Sowell, MO; Vassilev, PM; Ye, C | 1 |
| Favilla, S; Ghiadoni, L; Magagna, A; Pompella, A; Salvetti, A; Taddei, S; Virdis, A | 1 |
| Karlsson, JO; Lossius, K; Persson, AA; Støen, R | 1 |
| Arakawa, N; Hiramori, K; Nagano, M; Naganuma, Y; Nakamura, M; Yoshida, H | 1 |
| Chuan, P; Domenech, C; Lluch, S; Medina, P; Segarra, G; Vila, JM | 1 |
| Fukuo, K; Kaimoto, T; Ogihara, T; Sato, N; Suhara, T; Suzuki, T; Takemura, Y; Yang, J; Yasuda, O | 1 |
| Hälinen, M; Haverinen, J; Vornanen, M | 1 |
2 trial(s) available for omega-n-methylarginine and nifedipine
| Article | Year |
|---|---|
Divergent effects of ACE-inhibition and calcium channel blockade on NO-activity in systemic and renal circulation in essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiac Output; Dose-Response Relationship, Drug; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Renal Circulation; Vascular Resistance | 1998 |
Nitric oxide plays an insignificant role in direct vasodilator effects of calcium channel blockers in healthy humans.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Diltiazem; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Heart Rate; Humans; Male; Nicardipine; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Plethysmography; Vasodilation; Vasodilator Agents | 2002 |
12 other study(ies) available for omega-n-methylarginine and nifedipine
| Article | Year |
|---|---|
Phenylephrine-induced rhythmic activity in the rabbit ear artery.
Topics: Animals; Arginine; Arteries; Charybdotoxin; Ear, External; Endothelium, Vascular; Glyburide; In Vitro Techniques; Indomethacin; Male; Nifedipine; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Periodicity; Phenylephrine; Potassium Channel Blockers; Prostaglandin Antagonists; Rabbits; Scorpion Venoms; Vasoconstriction | 1993 |
Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery.
Topics: Animals; Arginine; Coronary Vessels; Endothelium, Vascular; Female; In Vitro Techniques; Isometric Contraction; Male; Membrane Potentials; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Potassium; Substance P; Swine | 1994 |
Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cell Line; Cycloheximide; Dexamethasone; Enzyme Induction; Hemodynamics; Lipopolysaccharides; Lung; Macrophages; Male; Mice; Muscle, Smooth; Nifedipine; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Rats; Rats, Wistar | 1993 |
Production of nitrite by dengue virus-induced cytotoxic factor.
Topics: Animals; Antibodies, Blocking; B-Lymphocytes; Biological Assay; Calcium; Cells, Cultured; Culture Media; Cytokines; Dengue; Dose-Response Relationship, Drug; Macrophages; Mice; Nifedipine; Nitrites; omega-N-Methylarginine; Spleen; T-Lymphocytes | 1996 |
Nifedipine attenuates systemic and renal vasoconstriction during nitric oxide inhibition in humans.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Drug Interactions; Enzyme Inhibitors; Hemodynamics; Humans; Infusions, Intravenous; Male; Nifedipine; Nitric Oxide; omega-N-Methylarginine; Renal Circulation; Vasoconstriction | 1997 |
Inhibition of nitric oxide synthase slows heart rate recovery from cholinergic activation.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Arginine; Calcium Channel Blockers; Cardiovascular Agents; Cesium; Electric Stimulation; Enzyme Inhibitors; Guinea Pigs; Heart Atria; Heart Rate; Male; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Pyrimidines; Vagus Nerve | 1998 |
Galpha(i2), Galpha(i3)and Galpha(o) are all required for normal muscarinic inhibition of the cardiac calcium channels in nodal/atrial-like cultured cardiocytes.
Topics: Action Potentials; Animals; Calcium Channels; Calcium Channels, L-Type; Carbachol; Cell Line; GTP-Binding Proteins; Heart; Heart Ventricles; Isoproterenol; Mice; Models, Cardiovascular; Molsidomine; Muscarinic Antagonists; Myocardium; Nifedipine; Nitric Oxide Donors; omega-N-Methylarginine; Pertussis Toxin; Receptors, Muscarinic; Stem Cells; Virulence Factors, Bordetella | 1999 |
Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
Topics: Acetylcholine; Antioxidants; Ascorbic Acid; Blood Pressure; Calcium Channel Blockers; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxidative Stress; Regional Blood Flow; Time Factors; Vasodilation | 2001 |
Relative significance of the nitric oxide (NO)/cGMP pathway and K+ channel activation in endothelium-dependent vasodilation in the femoral artery of developing piglets.
Topics: Acetylcholine; Animals; Animals, Newborn; Calcium Channel Blockers; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Femoral Artery; Male; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Potassium; Potassium Channels; Swine; Vasodilation; Vasodilator Agents | 2001 |
Increased contraction to noradrenaline by vasopressin in human renal arteries.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nifedipine; Norepinephrine; omega-N-Methylarginine; Potassium Chloride; Renal Artery; Vasoconstriction; Vasoconstrictor Agents | 2002 |
Nifedipine upregulates manganese superoxide dismutase expression in vascular smooth muscle cells via endothelial cell-dependent pathways.
Topics: Blotting, Western; Calcium Channel Blockers; Cell Division; Cells, Cultured; Coculture Techniques; Endothelial Cells; Enzyme Inhibitors; Humans; Muscle, Smooth, Vascular; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oligonucleotides, Antisense; omega-N-Methylarginine; Superoxide Dismutase; Tubulin; Up-Regulation | 2003 |
Sinoatrial tissue of crucian carp heart has only negative contractile responses to autonomic agonists.
Topics: Acclimatization; Action Potentials; Animals; Calcium Channels; Calcium Channels, L-Type; Carbachol; Carps; Cholinergic Agonists; Cold Temperature; Enzyme Inhibitors; Heart Rate; Hot Temperature; Hypoxia; Isoproterenol; Myocardial Contraction; Nifedipine; Nitric Oxide Synthase; omega-N-Methylarginine; Parasympathetic Nervous System; Potassium Channels; Seasons; Sinoatrial Node; Species Specificity; Sympathetic Nervous System | 2010 |